Eplerenone Observational Study Of Safety And Efficacy Evaluation To Normalize Blood Pressure For Clinical Effectiveness
Phase of Trial: Phase IV
Latest Information Update: 27 Jan 2014
At a glance
- Drugs Eplerenone (Primary)
- Indications Hypertension
- Focus Adverse reactions
- Acronyms ESSENCE
- Sponsors Pfizer
- 15 Jan 2013 Planned End Date changed from 1 Oct 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Aug 2012 Planned end date changed from 1 Jun 2013 to 1 Oct 2012 as reported by ClinicalTrials.gov record.